Data elements for the IMMZ.D1.Capture or update client history Data Dictionary Activity.

The patient.

Indicates if the client received a dose within 24 hours of birth. Whether a birth dose is counted as part of the primary series will depend on the antigen

The type of dose in a series that the client received

Indicates if the client has completed the primary vaccination series of a product/antigen. If the client has not yet completed their primary series, it means they may be expected to receive more doses to complete their vaccination regimen for the respective product/antigen

Indicates if the client has completed the booster series of a product/antigen

The date when the client completed the primary vaccination series (per product/antigen)

The current HIV status of the client

The infant was preterm; the mother gave birth to the infant when gestational age was less than 37 weeks

The client is known to be immunocompromised. This means the client has a weakened immune system and having a reduced ability to fight infections and other diseases

The client is currently receiving antiretroviral therapy (ART)

The type of tuberculosis (TB) infection test performed

Records the result of the TB infection test

The client is living with HIV and is immunologically stable with CD4 count or percentage above a minimum as defined in the HIV guidelines

The client is living with HIV and is clinically well, as defined in HIV guidelines and WHO clinical staging

Represents the client's birth weight value measures in grams

The type of the poliovirus vaccine dose administered to the client

The date on which the client started or restarted ART

The client is at high risk for pneumococcal infection because of underlying medical conditions (i.e. HIV infection or sickle-cell disease)

The type of Japanese encephalitis (JE) vaccine dose administered to the client

The type of tick-borne encephalitis (TBE) vaccine dose administered

The type of typhoid vaccine dose administered to the client

The type of cholera vaccine dose administered to the client

The type of meningococcal vaccine dose administered to the client

The age in months when client received their first meningococcal dose

The type of hepatitis A-containing vaccine dose administered to the client

The type of hepatitis B-containing vaccine dose administered to the client

Vaccine-induced neutralizing antibody (VNA) level, measured as a serum antibody concentration from the result of the concentrated, purified cell culture-derived and embryonated egg-based rabies vaccines (CCEEV)

Professional at risk of occupational exposure to rabies virus, particularly animal health workers. Also considered for medical professionals who regularly provide care to persons with rabies

Indicates the result of a serological test determining whether the client has antibodies against the dengue virus

Vaccine type/category that was administered or was to be administered. Any vaccine code available in the IMMZ.Z Vaccine library list of codes applies in this data element

Represents the visit/encounter date, which is the date and time when each vaccine was administered to the client

The date and time of the client's contact

The antenatal care (ANC) contact or visit number

Vaccine dose number including dose number within series

Data elements for the IMMZ.D1.Capture or update client history Data Dictionary Activity.

The patient.

Indicates if the client received a dose within 24 hours of birth. Whether a birth dose is counted as part of the primary series will depend on the antigen

The type of dose in a series that the client received

Indicates if the client has completed the primary vaccination series of a product/antigen. If the client has not yet completed their primary series, it means they may be expected to receive more doses to complete their vaccination regimen for the respective product/antigen

Indicates if the client has completed the booster series of a product/antigen

The date when the client completed the primary vaccination series (per product/antigen)

The current HIV status of the client

The infant was preterm; the mother gave birth to the infant when gestational age was less than 37 weeks

The client is known to be immunocompromised. This means the client has a weakened immune system and having a reduced ability to fight infections and other diseases

The client is currently receiving antiretroviral therapy (ART)

The type of tuberculosis (TB) infection test performed

Records the result of the TB infection test

The client is living with HIV and is immunologically stable with CD4 count or percentage above a minimum as defined in the HIV guidelines

The client is living with HIV and is clinically well, as defined in HIV guidelines and WHO clinical staging

Represents the client's birth weight value measures in grams

The type of the poliovirus vaccine dose administered to the client

The date on which the client started or restarted ART

The client is at high risk for pneumococcal infection because of underlying medical conditions (i.e. HIV infection or sickle-cell disease)

The type of Japanese encephalitis (JE) vaccine dose administered to the client

The type of tick-borne encephalitis (TBE) vaccine dose administered

The type of typhoid vaccine dose administered to the client

The type of cholera vaccine dose administered to the client

The type of meningococcal vaccine dose administered to the client

The age in months when client received their first meningococcal dose

The type of hepatitis A-containing vaccine dose administered to the client

The type of hepatitis B-containing vaccine dose administered to the client

Vaccine-induced neutralizing antibody (VNA) level, measured as a serum antibody concentration from the result of the concentrated, purified cell culture-derived and embryonated egg-based rabies vaccines (CCEEV)

Professional at risk of occupational exposure to rabies virus, particularly animal health workers. Also considered for medical professionals who regularly provide care to persons with rabies

Indicates the result of a serological test determining whether the client has antibodies against the dengue virus

Vaccine type/category that was administered or was to be administered. Any vaccine code available in the IMMZ.Z Vaccine library list of codes applies in this data element

Represents the visit/encounter date, which is the date and time when each vaccine was administered to the client

The date and time of the client's contact

The antenatal care (ANC) contact or visit number

Vaccine dose number including dose number within series

Data elements for the IMMZ.D1.Capture or update client history Data Dictionary Activity.

The patient.

Indicates if the client received a dose within 24 hours of birth. Whether a birth dose is counted as part of the primary series will depend on the antigen

The type of dose in a series that the client received

Indicates if the client has completed the primary vaccination series of a product/antigen. If the client has not yet completed their primary series, it means they may be expected to receive more doses to complete their vaccination regimen for the respective product/antigen

Indicates if the client has completed the booster series of a product/antigen

The date when the client completed the primary vaccination series (per product/antigen)

The current HIV status of the client

The infant was preterm; the mother gave birth to the infant when gestational age was less than 37 weeks

The client is known to be immunocompromised. This means the client has a weakened immune system and having a reduced ability to fight infections and other diseases

The client is currently receiving antiretroviral therapy (ART)

The type of tuberculosis (TB) infection test performed

Records the result of the TB infection test

The client is living with HIV and is immunologically stable with CD4 count or percentage above a minimum as defined in the HIV guidelines

The client is living with HIV and is clinically well, as defined in HIV guidelines and WHO clinical staging

Represents the client's birth weight value measures in grams

The type of the poliovirus vaccine dose administered to the client

The date on which the client started or restarted ART

The client is at high risk for pneumococcal infection because of underlying medical conditions (i.e. HIV infection or sickle-cell disease)

The type of Japanese encephalitis (JE) vaccine dose administered to the client

The type of tick-borne encephalitis (TBE) vaccine dose administered

The type of typhoid vaccine dose administered to the client

The type of cholera vaccine dose administered to the client

The type of meningococcal vaccine dose administered to the client

The age in months when client received their first meningococcal dose

The type of hepatitis A-containing vaccine dose administered to the client

The type of hepatitis B-containing vaccine dose administered to the client

Vaccine-induced neutralizing antibody (VNA) level, measured as a serum antibody concentration from the result of the concentrated, purified cell culture-derived and embryonated egg-based rabies vaccines (CCEEV)

Professional at risk of occupational exposure to rabies virus, particularly animal health workers. Also considered for medical professionals who regularly provide care to persons with rabies

Indicates the result of a serological test determining whether the client has antibodies against the dengue virus

Vaccine type/category that was administered or was to be administered. Any vaccine code available in the IMMZ.Z Vaccine library list of codes applies in this data element

Represents the visit/encounter date, which is the date and time when each vaccine was administered to the client

The date and time of the client's contact

The antenatal care (ANC) contact or visit number

Vaccine dose number including dose number within series